The historical rank and industry rank for West Pharmaceutical Services's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, West Pharmaceutical Services's highest Yield on Cost was 0.88. The lowest was 0.18. And the median was 0.41.
MEX:WST's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.34 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
West Pharmaceutical Services (MEX:WST) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
West Pharmaceutical Services 5-Year Yield-on-Cost % Related Terms
MEX:WST vs RMD, MDLN, COO: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's 5-Year Yield-on-Cost % falls into.
West Pharmaceutical Services 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
West Pharmaceutical Services (MEX:WST) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on West Pharmaceutical Services and its competitors. Over the past decade, West Pharmaceutical Services' 5-Year Yield-on-Cost % has ranged from 0.18 to 0.88. According to the industry distribution chart, West Pharmaceutical Services ranks #302 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 92.4%.
Is West Pharmaceutical Services' 5-Year Yield-on-Cost % too high?
West Pharmaceutical Services' current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 0.88. Based on the distribution chart, West Pharmaceutical Services ranks #302 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, West Pharmaceutical Services has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does West Pharmaceutical Services' 5-Year Yield-on-Cost % compare to RMD and MDLN?
According to the Medical Devices & Instruments industry distribution chart, West Pharmaceutical Services ranks #302 out of 327 companies for 5-Year Yield-on-Cost %. This places West Pharmaceutical Services in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.34. Historically, West Pharmaceutical Services' own 5-Year Yield-on-Cost % has ranged from 0.18 to 0.88 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.34, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on West Pharmaceutical Services and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. West Pharmaceutical Services's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is West Pharmaceutical Services stock overvalued right now?
West Pharmaceutical Services (MEX:WST) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is MXN5,237.10, compared to a current price of MXN5,112.51 — trading 2.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. West Pharmaceutical Services' overall GF Score™ is 95/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For West Pharmaceutical Services (MEX:WST), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is West Pharmaceutical Services (MEX:WST) Overvalued in 2026?
Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be undervalued.
The current stock price of MXN5,112.51 is trading 2.4% below its estimated GF Value™ of MXN5,237.10.
Key valuation signals for MEX:WST:
5-Year Yield-on-Cost %: 0.00
GF Value™: MXN5,237.10 vs. price of MXN5,112.51 (2.4% below fair value)
No single metric tells the full story. See the MEX:WST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
95GF Score
Get the complete analysis for MEX:WST
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:WST has been successfully added to your 